Refobacin Bone Cement R (110034355)
Bone Cement. 510(k) K254107, from Biomet France (Valence, FR). Product code LOD, class 2.
As of Nov 19, 2026, K254107 is an FDA 510(k) held by Biomet France, substantially equivalent on Apr 15, 2026 after 117 days, with no recalls tied to it in FDA's recall database.
- Review time: 117 days
- Recalls: 0
21 CFR 807.92(a)(5) Refobacin Bone Cement R is indicated to be used for stable anchoring of suitable joint prostheses to the bone, in hip and knee revision arthroplasty operations when reconstruction is necessary because of revision of previous arthroplasty procedures due to joint infection, also in case an infection with gentamicin-sensitive strains is a potential risk.
- Refobacin Bone Cement RK171540 · Biomet, Inc. · Aug 30, 2017
- SPECTRUM GV Bone CementK250760 · Osteoremedies, LLC · Apr 2, 2025
- Osteopal® VK241674 · Heraeus Medical GmbH · Dec 5, 2024
- SPECTRUM® GV Bone CementK231556 · Osteoremedies, LLC · Dec 20, 2023
- Bone Cement Genta, Bone Cement HV, Bone Cement LVK211163 · Tecres S.P.A. · Jan 9, 2023
- Bone Cement-Normal ViscosityK212729 · Biomecanica Industria E Comerciode Produtos Ortopedicos Ltda · May 31, 2022
- OGM 1 Polymethylmethacrylate (PMMA) bone cement, OGM 1A Polymethylmethacrylate (PMMA) bone cementK211869 · Ormed Grup Medikal Turizm Saglik Hizmetleri Sanayi VE · May 19, 2022
- PALACOS MV proK213812 · Heraeus Medical GmbH · Feb 2, 2022
- PALACOS R pro, PALACOS R+G pro, PALACOS MV+G proK210607 · Heraeus Medical GmbH · Jul 9, 2021
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Dec 19, 2025
- Review panel
- Orthopedic
- Regulation
- 21 CFR 888.3027
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files